Strategic Execution and Market Dynamics
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here.
Achieved 4% currency-neutral net sales growth driven by the One Interface strategy, which integrates global functions to support local selling teams and enhances commercial productivity.
Performance was broad-based across all regions and segments, with Healthcare notably delivering 19% global billings growth on top of a 28% comp from the prior year.
Operational improvements, including automation and robotics in Europe and Australia, contributed significantly to margin expansion by reducing costs and increasing throughput.
The Corporate Office segment grew 5% globally, benefiting from a ‘flight to quality’ in Class A spaces and the need for companies to redesign offices for collaboration and talent retention.
Innovation remains a core driver, with the launch of noravant timber expanding the addressable market by offering rubber flooring performance with a wood grain aesthetic for healthcare patient rooms.
Sustainability initiatives resulted in a 4% reduction in product carbon footprint year-over-year, with 51% of materials now being recycled or bio-based, the highest in the industry.
The Interface Design Studio is serving as a competitive differentiator by helping customers navigate complex flooring specifications across the company’s diversified portfolio.
Outlook and Strategic Assumptions
Raised full-year 2026 guidance based on a strong 22% year-to-date increase in backlog and continued order momentum across all geographies.
Management anticipates a second-half gross margin run rate of approximately 39%, representing a 60 basis point improvement over the prior year’s baseline.
Guidance assumes the flow-through of low single-digit raw material inflation in future quarters, which is expected to be offset by proactive pricing implemented in Q2.
The company is focused on reaching 2030 science-based sustainability targets and remains committed to becoming carbon negative by 2040 without the use of offsets.
Capital allocation priorities remain balanced between investing in automation/innovation, managing leverage, evaluating M&A, and returning cash to shareholders.
Non-Recurring Items and Risk Factors
Recognized a $15.6 million benefit from IEEPA tariff refunds in Q2, contributing approximately $0.19 to earnings per diluted share; no further refunds are assumed in the guidance.
Adjusted SG&A increased to $103.1 million, primarily driven by higher sales commissions and variable compensation resulting from exceeding sales and profit targets.
Management noted that 15% to 20% of cost of goods sold remains subject to ongoing tariffs, which are factored into the current guidance.
Foreign currency exchange variances impacted reported SG&A expenses when translating international results into U.S. dollars.
